The alkaloid-based drugs market is projected to reach $4.8 billion by 2030 at an 8.8% CAGR, driven by plant-derived therapeutics, oncology applications, and extraction innovations.
Read More
The alexipharmic drugs market is projected to reach $4.02 billion by 2030 at a 4.5% CAGR, driven by antidote innovations, AI diagnostics, and growing homecare adoption.
Read More
Alcohol-free disinfectant foam market to reach $4.44 billion by 2030 at 14% CAGR, driven by increasing focus on hygiene and cleanliness.
Read More
The alcohol excipients market is projected to reach $4.66 billion by 2030 at an 8.2% CAGR, driven by biologics growth, personalized medicine, and advanced drug delivery.
Read More
The albuterol sulfate metered dose inhalers market is projected to reach $7.61 billion by 2030 at an 8.1% CAGR, driven by eco-friendly inhalers, homecare use, and patient-centric designs.
Read More
The albuterol market is projected to reach $6.57 billion by 2030 at a 6.8% CAGR, driven by rising asthma & COPD cases, homecare therapies, and rapid-relief inhalers.
Read More
The albumin excipient market is projected to reach $7.15 billion by 2030 at a 6.9% CAGR, driven by biopharma growth, protein excipient innovations, and advanced drug delivery.
Read More
The AI in bioinformatics market is projected to reach $37.63 billion by 2030 at a 43.7% CAGR, driven by precision medicine, AI-driven drug discovery, and genomic data analysis.
Read More
The aesthetic medicine market is projected to reach $110.76 billion by 2030 at an 8.4% CAGR, driven by non-invasive treatments, AI-driven planning, and personalized cosmetic solutions.
Read More
Advanced therapy medicinal products market to reach $124.43 by 2030 at 19.3% CAGR, driven by precision medicine, gene therapies, and biotech innovation.
Read More